| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/08/2011 | CN101569692B Compound health herb tea |
| 06/08/2011 | CN101554463B Drug for treating gynecologic and andrological diseases and preparation method thereof |
| 06/08/2011 | CN101549035B Medicament for treating cerebral thrombosis and sequela diseases and preparation method thereof |
| 06/08/2011 | CN101461882B Extract of Pericarpium trichosanthis and Allium macrostemon, and preparation method thereof |
| 06/08/2011 | CN101461843B Medicament composition for ischemic disease and application thereof in medicinal preparation |
| 06/08/2011 | CN101357901B Chiral 1,4-dihydro-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic carboxylate, preparation method and application thereof |
| 06/08/2011 | CN101352540B Nutritive health product and preparation method thereof |
| 06/08/2011 | CN101337932B Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)amino-phenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these |
| 06/08/2011 | CN101328152B Piperazidine compound and pyridine compound |
| 06/08/2011 | CN101314763B Short bifidobacteria with functions of anti-gastrointestinal tract pathogen, oxidation resistance and blood pressure reduction and its uses |
| 06/08/2011 | CN101288691B Chinese medicinal extracts for treating 'two high, one low', capsules and preparation method thereof |
| 06/08/2011 | CN101200721B Human myocardium protecting gene and uses thereof |
| 06/08/2011 | CN101185752B Medicinal composition for treating heat heart failure and preparation method and application thereof |
| 06/08/2011 | CN101175490B Agent for improving circulatory disorder |
| 06/08/2011 | CN101084959B Traditional Chinese medicinal composition containing ligusticum wallichii, notoginseng and borneol or storax and preparation thereof |
| 06/08/2011 | CN101080404B Pyrimidinylisoxazol derivative |
| 06/08/2011 | CN101062088B Cardiac and cerebral vascular disease treating medicine, the preparing method, the quality control method and the function thereof |
| 06/07/2011 | US7956219 Amino acid analogues |
| 06/07/2011 | US7956187 Method for decreasing opioid metabolism |
| 06/07/2011 | US7956093 For example, N-(1-Carbamoyl-1-oxo-3-phenylpropan-2-yl)-2-(E-2-(4-(1-pyrrolidinylmethyl)phenyl)ethen-1-yl)benzamide; calcium channel blockers; cardiovascular disorders; antiarthritic agents; inhibitors of enzymes, especially cysteine proteases such as calpain and cathepsins |
| 06/07/2011 | US7956040 Combination of catechin and quercetin for pharmaceutical or dietary use |
| 06/07/2011 | US7956036 Polypeptide and DNA thereof useful as a neovascular marker |
| 06/07/2011 | CA2555824C Fused-ring 4-oxopyrimidine derivative |
| 06/07/2011 | CA2483164C Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 06/07/2011 | CA2456977C Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies |
| 06/07/2011 | CA2442194C Novel peptide sy |
| 06/07/2011 | CA2435685C Desaturase genes and uses thereof |
| 06/07/2011 | CA2434035C Use of a strain of lactobacillus reducing the risk factors involved in the metabolic syndrome |
| 06/07/2011 | CA2423190C Angiogenic agents and their uses |
| 06/07/2011 | CA2306216C The use of inhibitors of the renin-angiotensin system for the treatment of cachexia and wasting |
| 06/03/2011 | WO2011066417A2 Antibodies and conjugates for modulators of angiogenesis |
| 06/03/2011 | WO2011066201A2 Methods and systems for treating and preventing cardiac injury in dystrophic subjects |
| 06/03/2011 | WO2011066182A2 Socs3 inhibition promotes cns neuron regeneration |
| 06/03/2011 | WO2011065519A1 Substituted oxopiperazine compound |
| 06/03/2011 | WO2011065444A1 Antithrombotic agent |
| 06/03/2011 | WO2011065389A1 Method for screening of therapeutic agent for hyperlipemia |
| 06/03/2011 | WO2011064753A1 Pharmaceutical compositions and therapeutic applications of a hydrocortisone derivative designated as deina |
| 06/03/2011 | WO2011064657A2 Quinazolin-4(3a)-one derivatives and methods of use thereof |
| 06/03/2011 | WO2011064376A1 Imidazole derivatives as aldosterone synthase inhibitors |
| 06/03/2011 | WO2011064189A1 Novel polymorphic shapes of methyl{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-5-yl)carbamate |
| 06/03/2011 | WO2011064130A1 Pharmaceutical composition comprising mirna-100 and its use in the modulation of blood vessel growth and endothelial inflammation |
| 06/03/2011 | WO2011063764A1 Azilsartan organic amine salts, preparation method and use thereof |
| 06/03/2011 | WO2011042473A3 Estrogen receptor ligands |
| 06/03/2011 | WO2011033225A3 Substituted 3-amino-cinnolin-4(1h)-one derivatives, preparation thereof, and therapeutic use thereof |
| 06/03/2011 | WO2011028416A3 Oral medication for the treatment of hemorrhoids and method of use |
| 06/03/2011 | WO2011028410A3 Topical medication for the treatment of hemorrhoids and method of use |
| 06/03/2011 | WO2011017108A3 Cyclopropyl modulators of p2y12 receptor |
| 06/03/2011 | WO2010141879A9 Peptides for transport of therapeutics and their carriers in mouse models and humans |
| 06/03/2011 | CA2782224A1 Azilsartan organic amine salts, preparation method and use thereof |
| 06/03/2011 | CA2782026A1 Pharmaceutical composition comprising mirna-100 and its use in the modulation of blood vessel growth and endothelial inflammation |
| 06/03/2011 | CA2781808A1 Novel polymorphic shapes of methyl{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-5-yl)carbamate |
| 06/03/2011 | CA2779875A1 Socs3 inhibition promotes cns neuron regeneration |
| 06/02/2011 | US20110130637 Protein product for modifying cardiovascular health |
| 06/02/2011 | US20110130469 Compositions and methods relating to resveratrol |
| 06/02/2011 | US20110130461 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
| 06/02/2011 | US20110130458 Krill oil process |
| 06/02/2011 | US20110130453 Aminoalkylphenyl antagonists of prostaglandin d2 receptors |
| 06/02/2011 | US20110130450 Pravastatin extraction |
| 06/02/2011 | US20110130447 Production of hop extracts having oestrogenic and antiproliferative bioactivity |
| 06/02/2011 | US20110130445 Substituted 3-phenylpropionic acids and the use thereof |
| 06/02/2011 | US20110130436 Caspase inhibitors and uses thereof |
| 06/02/2011 | US20110130434 Modified release ramipril compositions and uses thereof |
| 06/02/2011 | US20110130424 Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties |
| 06/02/2011 | US20110130419 Novel salt of isoquinoline compound and crystal thereof |
| 06/02/2011 | US20110130416 Pharmaceutical composition for treating hypertension and metabolic syndrome and use thereof |
| 06/02/2011 | US20110130415 Protein kinase c inhibitors and uses thereof |
| 06/02/2011 | US20110130414 Novel fused thiazolo and oxazolo pyrimidinones |
| 06/02/2011 | US20110130411 Process for preparing methyl carbamate and its purification for use as pharmaceutically active compound |
| 06/02/2011 | US20110130410 Process for preparing methyl methylcarbamate and its purification for use as pharmaceutically active compound |
| 06/02/2011 | US20110130407 Isoquinolinone derivatives as nk3 antagonists |
| 06/02/2011 | US20110130404 Quinoxalinedione derivatives |
| 06/02/2011 | US20110130400 Trpv4 antagonists |
| 06/02/2011 | US20110130396 Imidazothiadiazole derivatives |
| 06/02/2011 | US20110130395 P13k isoform selective inhibitors |
| 06/02/2011 | US20110130391 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 06/02/2011 | US20110130387 Sirtuin modulating compounds |
| 06/02/2011 | US20110130385 Bicyclic Heterocylic Derivatives and Methods of Use |
| 06/02/2011 | US20110130383 Use of Ion Channel Modulators in the Prophylaxis and Treatment of Inflammatory and Immunological Diseases |
| 06/02/2011 | US20110130380 Heteroaryl Kinase Inhibitors |
| 06/02/2011 | US20110130377 Substituted aryloxazoles and their use |
| 06/02/2011 | US20110130369 Use of fts for the treatment of myocardial ischemia/reperfusion injury |
| 06/02/2011 | US20110130364 Pyrrolopyridine derivatives substituted with cyclic amino group |
| 06/02/2011 | US20110130354 Sulfated oligosaccharide derivatives |
| 06/02/2011 | US20110130353 Highly purified antiendotoxin compound |
| 06/02/2011 | US20110130349 Compounds and Methods for Treating Toll-Like Receptor 2-Related Diseases and Conditions |
| 06/02/2011 | US20110130334 Methods and Compositions for Treatment of Reperfusion Injury and other Cardiac Conditions |
| 06/02/2011 | US20110130332 Relaxin Analogs |
| 06/02/2011 | US20110130326 Defensins for treatment of infective endocarditis |
| 06/02/2011 | US20110130325 Apoptosis-Modulating Protein Therapy for Proliferative Disorders and Nanoparticles Containing the Same |
| 06/02/2011 | US20110129896 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3Beta PROTEIN AND PROTEIN COMPLEXES |
| 06/02/2011 | US20110129553 Process for the preparation of sour cherry seed extract, use of the extract for the preparation of pharmaceutical compositions and pharmaceutical compositions containing said extract |
| 06/02/2011 | US20110129542 Substituted azepine- and diazepine-sulfonamides useful to inhibit 11beta-hydroxysteroid dehydrogenase type-1 |
| 06/02/2011 | US20110129535 Transdermal testosterone device and delivery |
| 06/02/2011 | US20110129530 Compressible-Coated Pharmaceutical Compositions and Tablets and Methods of Manufacture |
| 06/02/2011 | US20110129526 Compositions and methods for treating vascular disease |
| 06/02/2011 | US20110129523 Liposomally Encapsulated Reduced Glutathione, including with Other Pharmacologic Preparation, Capable of Administration as an Oral, Topical, Intraoral or Transmucosal, Prepartion, for Reversal and Prevention of Oxidation of Cholesterol and of Low Density Lipoprotein |
| 06/02/2011 | US20110129514 Hygroscopic coating on a balloon device |
| 06/02/2011 | US20110129511 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 06/02/2011 | US20110129472 Methods for controlling vasculogenesis |
| 06/02/2011 | US20110129464 Humanized anti-erbb2 antibodies and treatment with anti-erbb2 antibodies |